Longeveron (LGVN) Net Margin (QoQ) (2020 - 2026)
Longeveron (LGVN) Net Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Longeveron | 3.97 Mn | -11.79 Mn | 264,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,829.00 |
| Dec 31, 2025 | 377,930.00 |
| Sep 30, 2025 | -367,966.00 |
| Jun 30, 2025 | 11,385.00 |
| Mar 31, 2025 | -102,820.00 |
| Dec 31, 2024 | -8,584.00 |
| Sep 30, 2024 | 195,478.00 |
| Jun 30, 2024 | -175,850.00 |
| Mar 31, 2024 | 878,103.00 |
| Dec 31, 2023 | -563,225.00 |
| Sep 30, 2023 | -134,061.00 |
| Jun 30, 2023 | 1.27 Mn |
| Mar 31, 2023 | -1.16 Mn |
| Dec 31, 2022 | 156,053.00 |
| Sep 30, 2022 | -418,756.00 |
| Jun 30, 2022 | 26,485.00 |
| Mar 31, 2022 | -2.28 Mn |
| Dec 31, 2021 | 3.14 Mn |
| Sep 30, 2021 | -577,019.00 |
| Jun 30, 2021 | 107,234.00 |